Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Virginia Giuliani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2439-4986; OpenAlex author ID A5036705875. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers · 2025: none · 2026: 3 papers

Papers 9

  1. Author Correction: Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Co-author DOI 10.1038/s41586-026-10488-6↗
  2. Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. Co-author DOI 10.1038/s41586-026-10995-6↗
  3. DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-3849↗
  4. WRAD core perturbation impairs DNA replication fidelity promoting immunoediting in pancreatic cancer Co-author DOI 10.1101/2024.10.21.619543↗
  5. Clonal dominance defines metastatic dissemination in pancreatic cancer. Co-author DOI 10.1126/sciadv.add9342↗
  6. PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41467-021-24798-y↗
  7. Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. Co-author DOI 10.1038/nature21064↗
  8. In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer. Co-author DOI 10.1016/j.celrep.2016.05.063↗
  9. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Co-author DOI 10.1038/nature13611↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrea Viale · 9 shared papers, 2014–2026 · strength 1.03
  2. Alessandro Carugo · 9 shared papers, 2014–2026 · strength 1.03
  3. Timothy Paul Heffernan · 9 shared papers, 2014–2026 · strength 1.03
  4. Giannicola Genovese · 9 shared papers, 2014–2026 · strength 1.03
  5. Giulio Francesco Draetta · 9 shared papers, 2014–2026 · strength 1.03
  6. Huamin Wang · 6 shared papers, 2014–2026 · strength 0.68
  7. Haoqiang Ying · 6 shared papers, 2014–2026 · strength 0.67
  8. Wantong Yao · 5 shared papers, 2014–2026 · strength 0.58
  9. Jason B. Fleming · 6 shared papers, 2014–2026 · strength 0.58
  10. Ronald Anthony Depinho · 5 shared papers, 2014–2026 · strength 0.49
  11. Anirban Maitra · 5 shared papers, 2016–2026 · strength 0.48
  12. Francesca Citron · 3 shared papers, 2024–2026 · strength 0.45
  13. I-Lin Ho · 3 shared papers, 2024–2026 · strength 0.45
  14. Ziheng Chen · 3 shared papers, 2024–2026 · strength 0.45
  15. Luigi Perelli · 2 shared papers, 2024–2026 · strength 0.31
  16. Chiara Bonini · 2 shared papers, 2024–2026 · strength 0.31
  17. Piergiorgio Pettazzoni · 4 shared papers, 2014–2026 · strength 0.31
  18. Ya’an Kang · 3 shared papers, 2014–2026 · strength 0.27
  19. Lynda Chin · 3 shared papers, 2016–2026 · strength 0.26
  20. Avnish Kapoor · 2 shared papers, 2014–2026 · strength 0.23
  21. Lewis C. Cantley · 2 shared papers, 2014–2026 · strength 0.23
  22. Emanuela Brunetto · 2 shared papers, 2014–2026 · strength 0.23
  23. Alec C. Kimmelman · 2 shared papers, 2014–2026 · strength 0.23
  24. Costas Andreas Lyssiotis · 2 shared papers, 2014–2026 · strength 0.23
  25. Marco Dal Molin · 2 shared papers, 2017–2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.